Abate AS posts first positive cash flow as profit jumps tenfold on 67% revenue surge
The healthcare-focused firm hit ₹162 cr in revenue and ₹12.3 cr in profit in FY26, its best year yet, and is now planning a ₹50 cr expansion push.
What's new
- Abate AS revenue climbed 67% to nearly ₹162 cr in FY26; profit rose tenfold to ₹12.3 cr.
- The company posted its first-ever positive operating cash flow of ₹6.1 cr.
- Management outlined plans to push the healthcare revenue mix to 70-80% and flagged a ₹50 cr capex requirement.
Why this matters
The numbers are strong, but the real shift is strategic. Abate AS is deliberately pivoting toward healthcare services, targeting an 18-20% EBITDA margin and a dominant regional position. The ₹50 cr capital spend is the price of that transition, and the first positive cash flow gives it some internal funding to work with.
What we're watching
- How quickly the healthcare revenue mix actually reaches the 70-80% target.
- Whether the ₹50 cr capex is funded via debt, internal accruals, or equity.
- Margin stability as the company scales into higher-margin services.
The full read
Abate AS Industries just posted its best year. Revenue climbed 67% to nearly ₹162 cr, and profit jumped tenfold to ₹12.3 cr. The company also achieved its first positive operating cash flow of ₹6.1 cr, a key milestone that changes its funding profile. But the numbers are only half the story. Management laid out a clear plan to become a regional healthcare leader, targeting a healthcare revenue mix of 70-80% and an EBITDA margin of 18-20%. That transition will require ₹50 cr in capital expenditure, a significant commitment for a company this size. The first positive cash flow gives it a small internal war chest, but the open question is how it funds the rest. The pivot is on. Whether the margins follow is the next test.
Questions answered
- What drove Abate AS's profit to jump tenfold in FY26?
- A 67% revenue increase to nearly ₹162 cr, combined with a strategic shift toward higher-margin healthcare services, drove the tenfold profit jump to ₹12.3 cr. The company also achieved its first positive operating cash flow of ₹6.1 cr.
- What is the company's capex plan, and how much might it spend?
- Management flagged an estimated ₹50 cr capital expenditure requirement to support the expansion into a regional healthcare provider. The funding mix for this spend was not detailed in the transcript.
- What are the new margin targets?
- Abate AS is targeting an EBITDA margin of 18-20% as part of its pivot to healthcare services. This is a key forward-looking marker for updated valuation models.
- How does the healthcare revenue mix fit into the strategy?
- The company aims for a healthcare revenue mix of 70-80%, up from its current level. This transition is central to the plan to become a dominant regional healthcare provider with stable operating margins.